You have 9 free searches left this month | for more free features.

Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Osteoarthritis Trial in Canada (ATB-346 low dose, Placebo, ATB-346 mid-dose)

Completed
  • Osteoarthritis
  • ATB-346 low dose
  • +3 more
  • Mission, British Columbia, Canada
  • +34 more
Jul 20, 2022

CVD Risk Profile in Children With HCM

Recruiting
  • Hypertrophic Cardiomyopathy
    • Edmonton, Alberta, Canada
    • +9 more
    Aug 18, 2022

    Elbow Fracture, Elbow Injury, Elbow Dislocation Trial in Canada, United States (Lactose Placebo, Ketotifen Fumarate 2mg,

    Recruiting
    • Elbow Fracture
    • +2 more
    • Lactose Placebo
    • +2 more
    • Baltimore, Maryland
    • +16 more
    Dec 8, 2022

    Shoulder Arthritis, Anesthesia, Local, Local Infiltration Trial in London (100 mL of 0.9% normal saline (57ml), 0.5% ropivacaine

    Not yet recruiting
    • Shoulder Arthritis
    • +2 more
    • 100 mL of 0.9% normal saline (57ml), 0.5% ropivacaine (40 ml), 10 mg morphine (10 mg/ml), 0.1 mg of epinephrine (0.1 mg/ml), and 30 mg of ketorolac (30 mg/ml)
    • London, Ontario, Canada
      St. Josephs Healthcare London
    Jun 14, 2023

    Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4), Stage IIb Breast Cancer (T3N0) Trial in Canada (Whole-body FDG PET-CT

    Active, not recruiting
    • Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4)
    • Stage IIb Breast Cancer (T3N0)
    • Whole-body FDG PET-CT alone
    • Hamilton, Ontario, Canada
    • +5 more
    Apr 19, 2022

    Cancer, Tumour, Surgery Trial in Canada, United States (Tranexamic acid (TXA), Normal saline)

    Active, not recruiting
    • Cancer
    • +2 more
    • Tranexamic acid (TXA)
    • Normal saline
    • Rochester, Minnesota
    • +10 more
    Oct 25, 2022

    Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • Edmonton, Alberta, Canada
    • +9 more
    Jan 9, 2023

    Hyperactive Delirium, Delirium of Mixed Origin Trial (Dexmedetomidine Hydrochloride)

    Recruiting
    • Hyperactive Delirium
    • Delirium of Mixed Origin
    • Dexmedetomidine Hydrochloride
    • Calgary, Alberta, Canada
    • +3 more
    Dec 16, 2022

    Novel MRI Biomarkers for Monitoring Disease Progression in ALS

    Recruiting
    • Amyotrophic Lateral Sclerosis
    • Motor Neuron Disease
      • Miami, Florida
      • +8 more
      Jan 24, 2023

      Pancreatic Adenocarcinoma Trial in Canada (Gemcitabine, Nab-paclitaxel, Durvalumab)

      Active, not recruiting
      • Pancreatic Adenocarcinoma
      • Calgary, Alberta, Canada
      • +26 more
      May 9, 2022

      Myocardial Infarction, STEMI Trial in Canada (SMART AMI APPLICATION)

      Enrolling by invitation
      • Myocardial Infarction
      • STEMI
      • SMART AMI APPLICATION
      • Brantford, Ontario, Canada
      • +16 more
      Mar 11, 2022

      Breast Cancer, Breast Tumor Trial in Philadelphia ([18F]ISO-1)

      Active, not recruiting
      • Breast Cancer
      • Breast Neoplasm
      • Philadelphia, Pennsylvania
        University of Pennsylvania Hospital
      Jan 17, 2023

      Amyotrophic Lateral Sclerosis Trial in Worldwide (BIIB078)

      Terminated
      • Amyotrophic Lateral Sclerosis
      • La Jolla, California
      • +20 more
      Jan 31, 2023

      Metastatic Tumors Trial in Worldwide (radiation, drug, other)

      Recruiting
      • Metastatic Tumors
      • Palliative Radiation
      • +5 more
      • Melbourne, Victoria, Australia
      • +13 more
      Oct 13, 2022

      Acute Respiratory Distress Syndrome, Hypoxemic Respiratory Failure, ARDS, Human Trial in Canada (TheraPPP)

      Recruiting
      • Acute Respiratory Distress Syndrome
      • +2 more
      • TheraPPP
      • Calgary, Alberta, Canada
      • +16 more
      Jul 21, 2022

      Health-related Quality of Life in HIV-1 Infected Adults

      Active, not recruiting
      • HIV-1-infection
      • Montréal, Canada
      • +5 more
      Sep 22, 2022

      Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

      Suspended
      • Gastroenteropancreatic Neuroendocrine Tumor
      • Stanford, California
        Stanford Cancer Institute Palo Alto
      Sep 21, 2022

      Vasovagal Syncope Trial in Canada, Poland, United States (midodrine HCl, matching )

      Active, not recruiting
      • Vasovagal Syncope
      • midodrine hydrochloride
      • matching placebo
      • Minneapolis, Minnesota
      • +16 more
      Nov 1, 2022

      Patent Ductus Arteriosus After Premature Birth Trial in Hamilton, Toronto, Dublin (Acetaminophen Injection, Ibuprofen 20 mg/mL

      Recruiting
      • Patent Ductus Arteriosus After Premature Birth
      • Acetaminophen Injection
      • +2 more
      • Hamilton, Ontario, Canada
      • +3 more
      Jan 30, 2023

      Glabellar Frown Lines Trial in Canada, United States (Botulinum Toxins, Type A, Placebos)

      Completed
      • Glabellar Frown Lines
      • Botulinum Toxins, Type A
      • Placebos
      • Encinitas, California
      • +13 more
      Jun 29, 2022

      Kidney Stone Trial in Canada (LithoVue Elite)

      Not yet recruiting
      • Kidney Stone
      • LithoVue Elite
      • Vancouver, British Columbia, Canada
      • +5 more
      Aug 1, 2022

      Multiple Sclerosis Trial in Calgary, Edmonton, Kingston (MS INFoRm, Usual Care Control Group)

      Completed
      • Multiple Sclerosis
      • MS INFoRm
      • Usual Care Control Group
      • Calgary, Alberta, Canada
      • +2 more
      Apr 18, 2022

      The RAPID COVID-19 TRIAGE Algorithm

      Active, not recruiting
      • COVID-19
      • Spartan Cube Point-of Care Covid-19 test
      • Ottawa, Ontario, Canada
        University of Ottawa Heart Institute
      Jan 12, 2023

      Chin Augmentation and Correction Trial in Canada (Hyaluronic Acid)

      Completed
      • Chin Augmentation and Correction
      • Hyaluronic Acid
      • Calgary, Alberta, Canada
      • +8 more
      Jun 21, 2022

      Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL, Relapsed Pediatric ALL Trial in Calgary, Edmonton (autologous CD19-directed

      Recruiting
      • Relapsed Non Hodgkin Lymphoma
      • +2 more
      • autologous CD19-directed chimeric antigen receptor (CAR) T-cells
      • Calgary, Alberta, Canada
      • +5 more
      Jul 18, 2022